Synapse - Safety and immunogenicity of the 13-valent protein-conjugated pneumococcal vaccine(PCV13) following related and unrelated hematopoietic stem cell transplantation (HCT)

Safety and immunogenicity of the 13-valent protein-conjugated pneumococcal vaccine(PCV13) following related and unrelated hematopoietic stem cell transplantation (HCT) Meeting Abstract

Authors:	Small, T. N.; Jakubowski, A. A.; Barker, J. N.; Kernan, N. A.; Prockop, S. E.; Iovino, C. S.; Lestrange, N.; Perales, M. A.; Castro-Malaspina, H.; Koehne, G.; Giralt, S.; Papadopoulos, E. B.
Abstract Title:	Safety and immunogenicity of the 13-valent protein-conjugated pneumococcal vaccine(PCV13) following related and unrelated hematopoietic stem cell transplantation (HCT)
Meeting Title:	53rd Annual Meeting and Exposition of the American Society of Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis
Journal Title:	Blood
Volume:	118
Issue:	21
Meeting Dates:	2011 Dec 10-13
Meeting Location:	San Diego, CA
ISSN:	0006-4971
Publisher:	American Society of Hematology
Date Published:	2011-11-01
Start Page:	1309
Language:	English
ACCESSION:	WOS:000299597104388
PROVIDER:	wos
DOI:	10.1182/blood.V118.21.3037.3037
Notes:	--- - Meeting Abstract: 3037 - 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis - DEC 10-13, 2011 - San Diego, CA - "Source: Wos"